THOMPSON KIMBERLY KRAIG (CEO, CFO) sold 0.0% of their position (60K shares) of KRAIG BIOCRAFT LABORATORIES, INC. on the open market
Insider sale on the open market — a minor trim. Check remaining position size for full context.
S · 2 sales
Filed: 7/11/2022ACC: 0001493152-22-019012
DirectorOfficer10% Owner· CEO, CFO
Since Dec 2020
-60K
Net shares
Net seller
$0.00
Total acquired
2
Open market trades
0B · 2S
2
Total transactions
60K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−20K
Price / share
—
Trade value
—
% of position
0.0%
7/7/2022
202.06M→202.04M
Common Stock
Direct
Shares
−40K
Price / share
—
Trade value
—
% of position
0.0%
7/8/2022
202.04M→202M
Total
Net shares
−60K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/7/2022 | S · Sale | −20K | — | — | 0.0% | 202.06M | 202.04M |
| Common Stock Direct | 7/8/2022 | S · Sale | −40K | — | — | 0.0% | 202.04M | 202M |
| Total | −60K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported